Annual Total Debt
$15.06 M
-$931.00 K-5.82%
31 December 2021
Summary:
Concert Pharmaceuticals annual total debt is currently $15.06 million, with the most recent change of -$931.00 thousand (-5.82%) on 31 December 2021. During the last 3 years, it has fallen by -$931.00 thousand (-5.82%).CNCE Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$14.21 M
-$294.00 K-2.03%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly total debt is currently $14.21 million, with the most recent change of -$294.00 thousand (-2.03%) on 30 September 2022.CNCE Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -5.8% | -7.2% |
5 y5 years | +100.0% | -13.5% |
CNCE Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -27.0% | -51.3% |
Concert Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $14.21 M(-2.0%) |
June 2022 | - | $14.51 M(-1.9%) |
Mar 2022 | - | $14.79 M(-1.8%) |
Dec 2021 | $15.06 M(-5.8%) | $15.06 M(-1.6%) |
Sept 2021 | - | $15.31 M(-1.5%) |
June 2021 | - | $15.55 M(-1.5%) |
Mar 2021 | - | $15.78 M(-1.4%) |
Dec 2020 | $16.00 M(-1.6%) | $16.00 M(-1.2%) |
Sept 2020 | - | $16.19 M(-1.1%) |
June 2020 | - | $16.38 M(-1.1%) |
Mar 2020 | - | $16.56 M(+1.8%) |
Dec 2019 | $16.26 M(>+9900.0%) | $16.26 M(-1.0%) |
Sept 2019 | - | $16.43 M(-0.9%) |
June 2019 | - | $16.58 M(-0.9%) |
Mar 2019 | - | $16.73 M(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00 | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2017 | - | $0.00(-100.0%) |
June 2017 | - | $29.19 M(>+9900.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sept 2016 | - | $0.00(0.0%) |
June 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2015 | - | $775.00 K(-73.5%) |
June 2015 | - | $2.93 M(-41.9%) |
Mar 2015 | - | $5.04 M(-29.1%) |
Dec 2014 | $7.10 M(-54.2%) | $7.10 M(-22.1%) |
Sept 2014 | - | $9.12 M(-20.8%) |
June 2014 | - | $11.51 M(-14.9%) |
Mar 2014 | - | $13.52 M(-12.8%) |
Dec 2013 | $15.50 M(-24.9%) | $15.50 M(-11.1%) |
Sept 2013 | - | $17.43 M(>+9900.0%) |
June 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(-100.0%) |
Dec 2012 | $20.64 M(+146.3%) | $20.64 M |
Dec 2011 | $8.38 M | - |
FAQ
- What is Concert Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual total debt?
The current annual total debt of CNCE is $15.06 M
What is the all time high annual total debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual total debt is $20.64 M
What is Concert Pharmaceuticals quarterly total debt?
The current quarterly total debt of CNCE is $14.21 M
What is the all time high quarterly total debt for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly total debt is $29.19 M